Valuation: Diaceutics PLC

Market Cap 166M 219M 198M 183M 312M 20.64B 323M 2.2B 874M 11.02B 821M 804M 34.99B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 158M 209M 189M 175M 297M 19.66B 308M 2.1B 833M 10.5B 783M 766M 33.34B EV / Sales 2026 *
3.38x
EV / Sales 2027 * 2.74x
Free-Float
72.02%
Yield 2026 *
-
Yield 2027 * -
1 day-0.51%
1 week-4.90%
Current month-4.67%
1 month-4.20%
3 months+37.10%
6 months+12.79%
Current year+51.56%
1 week 178.5
Extreme 178.5
203
1 month 178.5
Extreme 178.5
210
Current year 125
Extreme 125
210
1 year 125
Extreme 125
210
3 years 82.5
Extreme 82.5
210
5 years 74
Extreme 74
210
10 years 74
Extreme 74
210
Manager TitleAgeSince
Chief Executive Officer 42 2023-12-31
Director of Finance/CFO - 2022-03-17
Chief Operating Officer - -
Director TitleAgeSince
Chairman 65 2024-09-30
Director/Board Member 42 -
Director/Board Member 42 2024-09-30
Date Insider Type Main position Quantity % Market Cap. Importance
5/5/26 Buy

Chief Financial Officer

90 0.0001%
5/5/26 Free

Chief Financial Officer

90 0.0001%
5/5/26 Free

Executive/Senior Manager

89 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-0.51%-4.90%+18.29%+124.28% 219M
+1.35%+0.72%+26.66%+73.98% 793B
-2.01%+1.70%+20.34%+68.68% 90.34B
-1.26%+7.15%+34.12%+144.53% 70.53B
+2.82%-1.28%+35.45%+62.22% 49.73B
+2.56%+0.11%-9.22%+9.04% 48.43B
-10.82%-9.82%+31.76%+483.90% 35.26B
+0.85%+6.77%+28.89%+32.89% 33.41B
+3.69%+1.07%-1.51%-47.72% 32.72B
+1.38%+1.48%+63.14%+101.57% 29.17B
Average -0.23%+1.16%+24.79%+105.34% 118B
Weighted average by Cap. +0.82%+0.38%+25.86%+83.01%

Financials

2026 *2027 *
Net sales 46.69M 61.73M 55.94M 51.74M 87.98M 5.82B 91.08M 622M 246M 3.11B 232M 227M 9.87B 56.66M 74.92M 67.89M 62.8M 107M 7.06B 111M 754M 299M 3.77B 281M 275M 11.98B
Net income -1.1M -1.45M -1.32M -1.22M -2.07M -137M -2.15M -14.65M -5.81M -73.26M -5.46M -5.34M -233M 2.85M 3.77M 3.42M 3.16M 5.37M 355M 5.56M 37.95M 15.05M 190M 14.14M 13.84M 603M
Net Debt -7.81M -10.33M -9.36M -8.65M -14.72M -974M -15.23M -104M -41.23M -520M -38.75M -37.93M -1.65B -10.45M -13.82M -12.52M -11.58M -19.7M -1.3B -20.39M -139M -55.17M -696M -51.86M -50.76M -2.21B
Projected Income Statement - Annual - Diaceutics PLC
Logo Diaceutics PLC
Diaceutics PLC is a United Kingdom-based company. The Company is engaged in research and development activities in the area of precision medicine data and platform software. It provides pharma and biotech companies with an end-to-end commercialization solution for precision medicine through data analytics, scientific and advisory services enabled by its platform DXRX - The Diagnostics Network. It has two separate products and service lines: Insight & Engagement Solutions (Data and related information services) and Scientific & Advisory Services (Professional services). Insight & Engagement Solutions includes access to the DXRX platform diagnostic testing data repository to utilize licensed data insight products, such as lab segmentation, physician segmentation, testing rate tracker and physician signal. Scientific Advisory Services comprise a range of services developed to help improve patient care by accelerating the development, delivery and uptake of precision medicine.
Employees
205
Date Price Change Volume
26-11-13 GBX 194.00 -0.51% 320,374
26-11-12 GBX 195.00 +9.24% 13,305,994
26-11-11 GBX 178.50 -7.27% 151,555
26-11-10 GBX 192.50 -2.53% 101,993
26-11-09 GBX 197.50 -1.50% 53,411
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Diaceutics PLC
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.950GBP
Average target price
2.370GBP
Spread / Average Target
+21.54%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Diaceutics PLC
  1. Stock Market
  2. Stocks
  3. DXRX Stock